NCT07079657

Thulium Laser and Growth Factors for Androgenetic Alopecia

Thulium Laser and Growth Factors for Androgenetic Alopecia - a Prospective, Clinical Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Universitätsklinikum Hamburg-Eppendorf · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Androgenetic alopecia (AGA) is a common cause of hair loss worldwide. It mainly affects the frontal and parietal regions of the scalp in up to 70 % of men and 40 % of women and has a significant negative psychological and emotional impact on those affected. Various therapies are currently approved for the treatment of AGA in men and women, including topical minoxidil, topical or systemic finasteride, platelet-rich plasma and hair transplantation. In addition to these pharmacological and surgical interventions, laser therapies including thulium laser with growth factors have gained popularity. Despite the clinical use of the thulium laser with growth factors in combination with LED phototherapy, there are only a few studies to date that have adequately investigated the objective and patient-side benefits of this therapy.

Conditions

• Androgenetic Alopecia (AGA)

Interventions

Type	Name	Description
PROCEDURE	Thulium laser + growth factor serum + LED	3 sessions at intervals of 6 weeks
PROCEDURE	Thulium laser + growth factor serum	3 sessions at intervals of 6 weeks
PROCEDURE	Thulium laser	3 sessions at intervals of 6 weeks

Timeline

• Start date: 2023-12-01
• Primary completion: 2025-09-01
• Completion: 2025-10-01
• First posted: 2025-07-23
• Last updated: 2025-07-23

Locations

1 site across 1 country: Germany